MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS AND METHODS OF USE THEREOF
申请人:The Board of Trustees of the
Leland Stanford Junior University
公开号:EP2126574B1
公开(公告)日:2015-12-23
Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof
申请人:The Board of Trustees of the Leland Stanford Junior University
公开号:US20150105456A1
公开(公告)日:2015-04-16
The present invention provides compounds that function as modulators of mitochondrial aldehyde dehydrogenase-2 (ALDH2) activity; and pharmaceutical compositions comprising the compounds. The present invention provides therapeutic methods involving administering a subject compound, or a subject pharmaceutical composition. The present invention further provides assays for identifying agonists of ALDH2.
US9102651B2
申请人:——
公开号:US9102651B2
公开(公告)日:2015-08-11
US9315484B2
申请人:——
公开号:US9315484B2
公开(公告)日:2016-04-19
[EN] MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS AND METHODS OF USE THEREOF<br/>[FR] MODULATEURS DE L'ALDÉHYDE DÉSHYDROGÉNASE-2 MITOCHONDRIAL, ET LEURS PROCÉDÉS D'UTILISATION
申请人:UNIV LELAND STANFORD JUNIOR
公开号:WO2008112164A2
公开(公告)日:2008-09-18
[EN] The present invention provides compounds that function as modulators of mitochondrial aldehyde dehydrogenase-2 (ALDH2) activity; and pharmaceutical compositions comprising the compounds. The present invention provides therapeutic methods involving administering a subject compound, or a subject pharmaceutical composition. The present invention further provides assays for identifying agonists of ALDH2. [FR] L'invention concerne des composés qui fonctionnent comme modulateurs d'activité d'aldéhyde déshydrogénase-2 mitochondrial (ALDH2); et des compositions pharmaceutiques comprenant les composés. La présente invention concerne des procédés thérapeutiques impliquant l'administration d'un composé de l'invention, ou d'une composition pharmaceutique de l'invention. La présente invention concerne en outre des dosages permettant d'identifier des agonistes d'ALDH2.